Why Medibank and NIB shares are outperforming today

Premium increases for 2024 have been announced.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) may be slipping into the red today, but the same cannot be said for Medibank Private Ltd (ASX: MPL) and NIB Holdings Limited (ASX: NHF) shares.

Both private health insurers are outperforming today with solid gains.

For example, Medibank shares are currently up 2% to $3.76, whereas NIB shares are up 3.5% to $7.85.

Health professional working on his laptop.

Image source: Getty Images

Why are Medibank and NIB shares outperforming?

Investors have been buying their shares this morning after the Australian Government gave the green light to premium increases in 2024.

According to a government release, the Albanese Government has approved an average industry premium increase of 3.03%.

Commenting on the increases, the release states:

The Albanese Government has ensured Australians get value for money from their private health insurance, with the average cost of private health insurance premiums rising at a much slower rate than the increase in wages, the age pension and inflation.

The 3.03 per cent increase is well below the annual rise in wages, social security payments and inflation, with wages rising by 4.2 per cent and inflation increasing by 4.1 per cent in 2023, and social security payments increasing in line with inflation.

NIB increases

NIB has been able to score a larger than average increase to its premiums.

An announcement this morning reveals that its 2024 health insurance premiums will rise by an average of 4.1% from 1 April 2024.

Its CEO, Mark Fitzgibbon, notes that the increase reflects the return of hospital and ancillary treatment post COVID-19, and a rise in health and medical treatment costs. He also highlights that claims inflation has moved back to long-term trends and believes it is crucial that insurers are able to price for this.

Mr Fitzgibbon commented:

We're not sitting back passively responding to inflationary pressure by just lifting premiums. We have a range of new measures designed to help members maintain good health as well as reduce out of pocket expenses. Essentially, we're trying to provide members with more value for their premiums.

Medibank will be increasing its premiums by a lower rate of 3.3% for 2024.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Healthcare Shares

Should I invest $10,000 into CSL shares? Yes or no

Is it time to pick up this fallen giant? Let's dig deeper into things.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »